ACHE and Alzheimer disease: On the other hand, treatment with nicotine or galantamine, this latter being an FDA approved acetylcholinesterase inhibitor for the symptomatic treatment of AD [98], significantly induced phagocytosis of extracellular toxic Aβ both in rat microglia and rodent models of AD.